Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426928 · ClinicalTrials.gov registry record
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
A clinical trial of HIPEC, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05426928 is a study of HIPEC that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05426928, a study of HIPEC, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a well-established alternative for patients with peritoneal surface malignancies. Although HIPEC has a predetermined protocol to manage body temperature, the resultant bladder and core-body temperatures are highly variable and unstable in clinical practice. Such results highlight an incomplete understanding of the thermodynamic processes during HIPEC in humans. Previous clinical and animal investigations have studied abdominal hyperthermia, but a full human model incorporating patient variables, heat delivery, and the impact of the circulatory system and anesthesia in HIPEC has not been established. This project seeks to develop and validate a computational thermodynamic model using prospective real-world data from humans undergoing HIPEC surgery. It is hypothesized that by incorporating patient, anesthetic, and perfusion-related variables in a thermodynamic model, the temperatures inside and outside the abdomen during HIPEC can be predicted.
Conditions Studied
Interventions
- OTHER Additional temperature monitoring/recording
Study Locations (1)
Michigan
- Katherine Nowak - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05426928
The ClinicalTrials.gov registry entry for NCT05426928 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIPEC appearing as the primary indexed condition, and to 1 intervention - of which Additional temperature monitoring/recording is the first listed.
NCT05426928 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05426928 about?
NCT05426928 is a clinical study titled "Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC". Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a well-established alternative for patients with peritoneal surface malignancies. Although HIPEC has a predetermined protocol to manage body temperature, the resultant bladder and core-body temperatures are highly variable and unstable in clinical...
What is the current status of trial NCT05426928?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-09-22. Estimated completion is 2027-03-31.
What conditions does trial NCT05426928 study?
This clinical trial studies the following conditions: HIPEC.
What interventions are being tested in trial NCT05426928?
The interventions under investigation include: Additional temperature monitoring/recording (OTHER).
Who is sponsoring clinical trial NCT05426928?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426928 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.